Gentamicin Sulfate Cream USP, 0.1%

Manufacturer
Padagis Israel Pharmaceuticals Ltd
Effective date
2023-01-31
Label type
HUMAN PRESCRIPTION DRUG LABEL
Version
13
Source
full-release
Hydrated at
2026-05-31 21:26:05

Label at a glance#

ProductGentamicin Sulfate
Active ingredientGENTAMICIN SULFATE
Label structure12 sections

Indications and uses

Primary skin infections: Impetigo contagiosa, superficial folliculitis, ecthyma, furunculosis, sycosis barbae, and pyoderma gangrenosum. Secondary skin infections: Infectious eczematoid dermatitis, pustular acne, pustular psoriasis, infected seborrheic dermatitis, infected contact dermatitis (including poison ivy), infected excoriations, and bacterial superinfections of fungal or viral infections. Please Note: Gen...

Dosage and administration

A small amount of Gentamicin Sulfate Cream USP, 0.1% should be applied gently to lesions three or four times a day. The area treated may be covered with a gauze dressing if desired. In impetigo contagiosa, the crusts should be removed before application of Gentamicin Sulfate Cream USP, 0.1% to permit maximum contact between the antibiotic and the infection. Care should be exercised to avoid further contamination o...

Storage and handling

Store at 20-25°C (68-77°F) [see USP Controlled Room Temperature].

Label contents#

Full prescribing information#

SPL UNCLASSIFIED SECTION

Rx Only

For Dermatologic Use Only

Not For Ophthalmic Use

DESCRIPTION

DESCRIPTION SECTION

Gentamicin Sulfate Cream USP, 0.1% is a wide spectrum antibiotic preparation for topical administration. Each gram of Gentamicin Sulfate Cream USP, 0.1% contains Gentamicin Sulfate USP equivalent to 1 mg of gentamicin base in a cream base of isopropyl myristate, propylene glycol, propylene glycol monostearate, polysorbate 40, purified water, sorbitol solution, and stearic acid, with methylparaben and butylparaben as preservatives.

CLINICAL PHARMACOLOGY

CLINICAL PHARMACOLOGY SECTION

Gentamicin Sulfate is a wide spectrum antibiotic that provides highly effective topical treatment in primary and secondary bacterial infections of the skin. Gentamicin Sulfate Cream USP, 0.1% may clear infections that have not responded to other topical antibiotic agents. In primary skin infections such as impetigo contagiosa, treatment three or four times daily with Gentamicin Sulfate Cream USP, 0.1% usually clears the lesions promptly. In secondary skin infections, Gentamicin Sulfate Cream USP, 0.1% aids in the treatment of the underlying dermatosis by controlling the infection. Bacteria susceptible to the action of gentamicin sulfate include sensitive strains of Streptococci (group A beta-hemolytic, alpha-hemolytic), Staphylococcus aureus (coagulase positive, coagulase negative, and some penicillinase-producing strains), and the gram-negative bacteria, Pseudomonas aeruginosa, Aerobacter aerogenes, Escherichia coli, Proteus vulgaris and Klebsiella pneumoniae.

INDICATIONS AND USAGE

INDICATIONS & USAGE SECTION

Primary skin infections: Impetigo contagiosa, superficial folliculitis, ecthyma, furunculosis, sycosis barbae, and pyoderma gangrenosum. Secondary skin infections: Infectious eczematoid dermatitis, pustular acne, pustular psoriasis, infected seborrheic dermatitis, infected contact dermatitis (including poison ivy), infected excoriations, and bacterial superinfections of fungal or viral infections. Please Note: Gentamicin Sulfate is a bactericidal agent that is not effective against viruses or fungi in skin infections. It is useful in the treatment of infected skin cysts and certain other skin abscesses when preceded by incision and drainage to permit adequate contact between the antibiotic and the infecting bacteria. Good results have been obtained in the treatment of infected stasis and other skin ulcers, infected superficial burns, paronychia, infected insect bites and stings, infected lacerations and abrasions, and wounds from minor surgery. Patients sensitive to neomycin can be treated with Gentamicin Sulfate, although regular observation of patients sensitive to topical antibiotics is advisable when such patients are treated with any topical antibiotic. Gentamicin Sulfate Cream USP, 0.1% is recommended for wet, oozing primary infections, and greasy, secondary infections, such as pustular acne or infected seborrheic dermatitis. Gentamicin sulfate ointment helps retain moisture and has been useful in infection on dry eczematous or psoriatic skin. If a water-washable preparation is desired, the cream is preferable. Gentamicin Sulfate Cream USP, 0.1% has been used successfully in infants over one year of age, as well as in adults and children.

CONTRAINDICATIONS

CONTRAINDICATIONS SECTION

This drug product is contraindicated in individuals with a history of sensitivity to any of its components.

PRECAUTIONS

PRECAUTIONS SECTION

The use of topical antibiotics occasionally allows overgrowth of nonsusceptible organisms, including fungi. If this occurs, or if irritation, sensitization, or superinfection develops, treatment with Gentamicin Sulfate should be discontinued and appropriate therapy instituted.

ADVERSE REACTIONS

ADVERSE REACTIONS SECTION

In patients with dermatoses treated with Gentamicin Sulfate, irritation (erythema and pruritus) that did not usually require discontinuance of treatment has been reported in a small percentage of cases. There was no evidence of irritation or sensitization, however, in any of these patients patch-tested subsequently with Gentamicin Sulfate on normal skin. Possible photosensitization has been reported in several patients but could not be elicited in these patients by reapplication of Gentamicin Sulfate followed by exposure to ultraviolet radiation.

DOSAGE AND ADMINISTRATION

DOSAGE & ADMINISTRATION SECTION

A small amount of Gentamicin Sulfate Cream USP, 0.1% should be applied gently to lesions three or four times a day. The area treated may be covered with a gauze dressing if desired. In impetigo contagiosa, the crusts should be removed before application of Gentamicin Sulfate Cream USP, 0.1% to permit maximum contact between the antibiotic and the infection. Care should be exercised to avoid further contamination of the infected skin. Infected stasis ulcers have responded well to Gentamicin Sulfate under gelatin packing.

HOW SUPPLIED

HOW SUPPLIED SECTION

Gentamicin Sulfate Cream USP, 0.1% is available as follows:

15 g tube (NDC 45802-056-35)

30 g tube (NDC 45802-056-11)

STORAGE

STORAGE AND HANDLING SECTION

Store at 20-25°C (68-77°F) [see USP Controlled Room Temperature].

SPL UNCLASSIFIED SECTION

Manufactured by Padagis®

Yeruham, Israel

www.padagis.com

Rev 01-23

7J200 RC PH1

Principal Display Panel - 15 g Cream Carton

PACKAGE LABEL.PRINCIPAL DISPLAY PANEL

NDC 45802-056-35

Rx Only

Gentamicin Sulfate Cream USP, 0.1%

NET WT 15 g

gentamycin sulfate cream carton
gentamycin sulfate cream carton

The following image is a placeholder representing the product identifier that is either affixed or imprinted on the drug package label during the packaging operation.

serialization-template.jpg
serialization-template.jpg

DailyMed RxNorm Mappings#

RxCUI, RxNorm string, TTY table
RxCUIRxNorm stringTTYSPL version
197735gentamicin sulfate 0.1 % Topical CreamPSN13
197735gentamicin 1 MG/ML Topical CreamSCD13
197735gentamicin (as gentamicin sulfate) 0.1 % Topical CreamSY13

DailyMed Pharmacologic Classes#

Class, Version, Type table
ClassVersionTypeEffective
GENTAMICIN Pharmacologic Class Indexing2Indexing - Pharmacologic Class20180813

DailyMed Product Concepts#

Product concept, Relation, Version table
Product conceptRelationVersionEffective
3b7b3a7a-635f-32a3-0c6c-7ad028e3de91Product name220250107
43025f0d-698c-68da-cec9-ea4261a7ef7aProduct name220250107
d3946667-8212-d1f2-67e1-5643a329bb56Product name220200403
4ce5dce5-e8a7-e4f6-0059-b527e4307477Product name220190501
48b05f5d-d2fc-45ab-76e8-3cb5bd44890dProduct name120140508

DailyMed Package Descriptions#

Package NDC, Product, Description table
Package NDCProductDescriptionFormQuantityStrengthSPL version
45802-056-11Gentamicin Sulfate30 g in 1 TUBECREAM3013
45802-056-11Gentamicin Sulfate1 in 1 CARTONCREAM113
45802-056-35Gentamicin Sulfate1 in 1 CARTONCREAM113
45802-056-35Gentamicin Sulfate15 g in 1 TUBECREAM1513

DailyMed Dashboard NDC Coverage#

NDC, Dashboard title, SPL version table
NDCDashboard titleSPL versionValidationDashboard ZIP
45802-056GENTAMICIN SULFATE CREAM [PADAGIS ISRAEL PHARMACEUTICALS LTD]13Current NDC, Legacy NDC, 4 package rows20250221_4cfbe37e-11d6-46fc-b287-0561387b17b7.zip

DailyMed Billing Units#

Package NDC, Billing unit, Product NDC table
Package NDCBilling unitProduct NDCDailyMed indexing SPLSPL versionEffective
45802-056-11GM - Gram45802-05663bbae86-a2c8-4c87-97c8-4e095a9de49212012-07-24
45802-056-35GM - Gram45802-0563629159e-c462-454d-aa64-f1d2ea2fa3c312012-07-24

DailyMed Socrata Ingredients#

Ingredient, Type, UNII table
IngredientTypeUNIISPL versionUploaded
GENTAMICIN SULFATEACTIVE INGREDIENT8X7386QRLV5
GENTAMICINACTIVE MOIETYT6Z9V48IKG5
BUTYLPARABENINACTIVE INGREDIENT3QPI1U3FV85
ISOPROPYL MYRISTATEINACTIVE INGREDIENT0RE8K4LNJS5
METHYLPARABENINACTIVE INGREDIENTA2I8C7HI9T5
POLYSORBATE 40INACTIVE INGREDIENTSTI11B5A2X5
PROPYLENE GLYCOLINACTIVE INGREDIENT6DC9Q167V35
PROPYLENE GLYCOL MONOPALMITOSTEARATEINACTIVE INGREDIENTF76354LMGR5
SORBITOLINACTIVE INGREDIENT506T60A25R5
STEARIC ACIDINACTIVE INGREDIENT4ELV7Z65AP5
WATERINACTIVE INGREDIENT059QF0KO0R5

Products#

Every source-derived product name is available through these pages.

DailyMed product names page 1 of 1 · 11 matching rows.

NDC Codes#

Product NDC, Package NDC table
Product NDCPackage NDC
45802-05645802-056-35, 45802-056-11

Ingredients#

Every source-derived ingredient row is available through these pages.

DailyMed ingredient rows page 1 of 1 · 10 matching rows.

Source Document#

Source XML

Inactive ingredient matches#

Inactive Ingredient Database values describe FDA-listed use contexts. The match method and ambiguity count are shown because ingredient names, routes, and dosage forms are not always unique. Browse recovered IID releases and source provenance.

Inactive ingredient links page 1 of 1 · 24 matching rows.

DailyMed ingredient, IID ingredient, UNII table
DailyMed ingredientIID ingredientUNIIDosage form / routePotencyMaximum daily exposureMatch
PROPYLENE GLYCOL MONOPALMITOSTEARATEPROPYLENE GLYCOL MONOPALMITOSTEARATEF76354LMGRCREAM / TOPICAL9.3 %w/wExact identifier — unii+route+dosage form
3 equally ranked IID candidates
BUTYLPARABENBUTYLPARABEN3QPI1U3FV8CREAM / TOPICAL0.4 %w/wExact identifier — unii+route+dosage form
3 equally ranked IID candidates
STEARIC ACIDSTEARIC ACID4ELV7Z65APCREAM / TOPICAL360 mgExact identifier — unii+route+dosage form
3 equally ranked IID candidates
PROPYLENE GLYCOLPROPYLENE GLYCOL6DC9Q167V3CREAM / TOPICAL76000 mgExact identifier — unii+route+dosage form
3 equally ranked IID candidates
BUTYLPARABENBUTYLPARABEN3QPI1U3FV8CREAM / TOPICAL0.4 %w/wExact identifier — unii+route+dosage form
3 equally ranked IID candidates
BUTYLPARABENBUTYLPARABEN3QPI1U3FV8CREAM / TOPICAL0.4 %w/wExact identifier — unii+route+dosage form
3 equally ranked IID candidates
PROPYLENE GLYCOLPROPYLENE GLYCOL6DC9Q167V3CREAM / TOPICAL76000 mgExact identifier — unii+route+dosage form
3 equally ranked IID candidates
STEARIC ACIDSTEARIC ACID4ELV7Z65APCREAM / TOPICAL360 mgExact identifier — unii+route+dosage form
3 equally ranked IID candidates
PROPYLENE GLYCOL MONOPALMITOSTEARATEPROPYLENE GLYCOL MONOPALMITOSTEARATEF76354LMGRCREAM / TOPICAL9.3 %w/wExact identifier — unii+route+dosage form
3 equally ranked IID candidates
METHYLPARABENMETHYLPARABENA2I8C7HI9TCREAM / TOPICAL3000 mgExact identifier — unii+route+dosage form
3 equally ranked IID candidates
PROPYLENE GLYCOL MONOPALMITOSTEARATEPROPYLENE GLYCOL MONOPALMITOSTEARATEF76354LMGRCREAM / TOPICAL9.3 %w/wExact identifier — unii+route+dosage form
3 equally ranked IID candidates
METHYLPARABENMETHYLPARABENA2I8C7HI9TCREAM / TOPICAL3000 mgExact identifier — unii+route+dosage form
3 equally ranked IID candidates
ISOPROPYL MYRISTATEISOPROPYL MYRISTATE0RE8K4LNJSCREAM / TOPICAL65000 mgExact identifier — unii+route+dosage form
3 equally ranked IID candidates
ISOPROPYL MYRISTATEISOPROPYL MYRISTATE0RE8K4LNJSCREAM / TOPICAL65000 mgExact identifier — unii+route+dosage form
3 equally ranked IID candidates
METHYLPARABENMETHYLPARABENA2I8C7HI9TCREAM / TOPICAL3000 mgExact identifier — unii+route+dosage form
3 equally ranked IID candidates
PROPYLENE GLYCOLPROPYLENE GLYCOL6DC9Q167V3CREAM / TOPICAL76000 mgExact identifier — unii+route+dosage form
3 equally ranked IID candidates
POLYSORBATE 40POLYSORBATE 40STI11B5A2XCREAM / TOPICAL3 %w/wExact identifier — unii+route+dosage form
3 equally ranked IID candidates
SORBITOLSORBITOL506T60A25RCREAM / TOPICAL36.8 %w/wExact identifier — unii+route+dosage form
3 equally ranked IID candidates
POLYSORBATE 40POLYSORBATE 40STI11B5A2XCREAM / TOPICAL3 %w/wExact identifier — unii+route+dosage form
3 equally ranked IID candidates
STEARIC ACIDSTEARIC ACID4ELV7Z65APCREAM / TOPICAL360 mgExact identifier — unii+route+dosage form
3 equally ranked IID candidates
POLYSORBATE 40POLYSORBATE 40STI11B5A2XCREAM / TOPICAL3 %w/wExact identifier — unii+route+dosage form
3 equally ranked IID candidates
SORBITOLSORBITOL506T60A25RCREAM / TOPICAL36.8 %w/wExact identifier — unii+route+dosage form
3 equally ranked IID candidates
SORBITOLSORBITOL506T60A25RCREAM / TOPICAL36.8 %w/wExact identifier — unii+route+dosage form
3 equally ranked IID candidates
ISOPROPYL MYRISTATEISOPROPYL MYRISTATE0RE8K4LNJSCREAM / TOPICAL65000 mgExact identifier — unii+route+dosage form
3 equally ranked IID candidates

Orange Book application contexts#

All distinct exact application/product contexts derived from this label’s complete NDC list are paginated below.

Orange Book application contexts page 1 of 1 · 1 matching rows.

Source provenance: Browse the complete Orange Book source catalog · source snapshot 45.

Orange Book products#

Current product rows page 1 of 1 · 1 matching rows.

Application-product, Trade name, Ingredient table
Application-productTrade nameIngredientStrengthDosage form / routeTE codesRLD / RSApproval date
A062307-001GENTAMICIN SULFATEGENTAMICIN SULFATEEQ 0.1% BASECREAM / TOPICALATRS, Approved before 1982

Therapeutic equivalence codes#

Current TE-code rows page 1 of 1 · 1 matching rows.

Application-product, TE code table
Application-productTE code
A062307-001AT

Observed Orange Book product history#

Observed FDA ZIP history: Each table is queried independently by exact application/product key from successfully parsed Orange Book snapshots. Capture times identify archived source observations; absence or a change between snapshots is not inferred. FDA publication files that were not recoverable as structured ZIP data are not represented as states.

Product history page 1 of 2 · 45 observed states.

Captured, Edition, Application-product table
CapturedEditionApplication-productTrade nameStrengthDosage form / routeProduct TE source textRLD / RSApproval dateSource SHA-256
2026-11-14 07:37:172026-10A062307-001GENTAMICIN SULFATEEQ 0.1% BASECREAM / TOPICALATRS, Approved before 1982d4dbc9d85df4…
2026-10-15 13:18:302026-09A062307-001GENTAMICIN SULFATEEQ 0.1% BASECREAM / TOPICALATRS, Approved before 1982c2088c7a36db…
2026-09-14 22:38:342026-08A062307-001GENTAMICIN SULFATEEQ 0.1% BASECREAM / TOPICALATRS, Approved before 198284e616aacf4f…
2026-08-18 06:07:402026-07A062307-001GENTAMICIN SULFATEEQ 0.1% BASECREAM / TOPICALATRS, Approved before 1982caaa826d4ba7…
2026-02-19 14:30 UTC2026-02A062307-001GENTAMICIN SULFATEEQ 0.1% BASECREAM / TOPICALATRS, Approved before 1982011fe1cb6892…
2025-12-14 10:44 UTC · 2 captures of this ZIP2025-12A062307-001GENTAMICIN SULFATEEQ 0.1% BASECREAM / TOPICALATRS, Approved before 198231067a03dcf5…
2025-08-23 18:47 UTC2025-08A062307-001GENTAMICIN SULFATEEQ 0.1% BASECREAM / TOPICALATRS, Approved before 19826a471c1ec25d…
2025-03-22 03:13 UTC · 3 captures of this ZIP2025-03A062307-001GENTAMICIN SULFATEEQ 0.1% BASECREAM / TOPICALATRS, Approved before 1982fd3edfee7708…
2025-02-26 10:13 UTC · 3 captures of this ZIP2025-02A062307-001GENTAMICIN SULFATEEQ 0.1% BASECREAM / TOPICALATRS, Approved before 1982b8a1b40f171c…
2025-01-19 17:59 UTC · 7 captures of this ZIP2025-01A062307-001GENTAMICIN SULFATEEQ 0.1% BASECREAM / TOPICALATRS, Approved before 198203ed91905a0d…
2024-12-13 21:23 UTC · 2 captures of this ZIP2024-12A062307-001GENTAMICIN SULFATEEQ 0.1% BASECREAM / TOPICALATRS, Approved before 19822680178bc6a6…
2024-09-14 05:58 UTC · 2 captures of this ZIP2024-09A062307-001GENTAMICIN SULFATEEQ 0.1% BASECREAM / TOPICALATRS, Approved before 19825bbf6a4d5a75…
2024-11-08 22:44 UTC · 3 captures of this ZIP2024-11A062307-001GENTAMICIN SULFATEEQ 0.1% BASECREAM / TOPICALATRS, Approved before 1982d8e5a09893c0…
2024-10-29 15:01 UTC2024-10A062307-001GENTAMICIN SULFATEEQ 0.1% BASECREAM / TOPICALATRS, Approved before 1982d06236e962d9…
2024-08-13 05:28 UTC · 3 captures of this ZIP2024-08A062307-001GENTAMICIN SULFATEEQ 0.1% BASECREAM / TOPICALATRS, Approved before 198279d66fd596c7…
2024-07-13 05:37 UTC · 2 captures of this ZIP2024-07A062307-001GENTAMICIN SULFATEEQ 0.1% BASECREAM / TOPICALATRS, Approved before 1982301d65b070ca…
2024-06-18 03:08 UTC · 5 captures of this ZIP2024-06A062307-001GENTAMICIN SULFATEEQ 0.1% BASECREAM / TOPICALATRS, Approved before 19821e350fbaab3a…
2024-05-31 18:47 UTC2024-05A062307-001GENTAMICIN SULFATEEQ 0.1% BASECREAM / TOPICALATRS, Approved before 19828072bd15b7f6…
2022-06-29 02:47 UTC · 2 captures of this ZIP2022-06A062307-001GENTAMICIN SULFATEEQ 0.1% BASECREAM / TOPICALATRS, Approved before 19825c6f7cd8ea54…
2022-04-08 23:34 UTC2022-04A062307-001GENTAMICIN SULFATEEQ 0.1% BASECREAM / TOPICALATRS, Approved before 19825d02ea3f76ae…
2022-04-04 05:41 UTC2022-04A062307-001GENTAMICIN SULFATEEQ 0.1% BASECREAM / TOPICALATRS, Approved before 19824b0b4de00fa7…
2019-12-13 00:20 UTC2019-12A062307-001GENTAMICIN SULFATEEQ 0.1% BASECREAM / TOPICALATRS, Approved before 198274a2ff9319b5…
2022-03-09 01:35 UTC2022-03A062307-001GENTAMICIN SULFATEEQ 0.1% BASECREAM / TOPICALATRS, Approved before 1982bb7c543d1eb4…
2021-12-28 21:50 UTC2021-12A062307-001GENTAMICIN SULFATEEQ 0.1% BASECREAM / TOPICALATRS, Approved before 1982782e0a99824c…
2021-05-05 16:15 UTC · 3 captures of this ZIP2021-05A062307-001GENTAMICIN SULFATEEQ 0.1% BASECREAM / TOPICALATRS, Approved before 198287673890dc5c…
2021-03-12 10:30 UTC2021-03A062307-001GENTAMICIN SULFATEEQ 0.1% BASECREAM / TOPICALATRS, Approved before 19825aa47cf7b7d7…
2020-12-22 03:56 UTC2020-12A062307-001GENTAMICIN SULFATEEQ 0.1% BASECREAM / TOPICALATRS, Approved before 19828869cabd3fbd…
2020-11-12 02:37 UTC2020-11A062307-001GENTAMICIN SULFATEEQ 0.1% BASECREAM / TOPICALATRS, Approved before 1982c0c555d07b60…
2019-12-14 00:12 UTC2019-12A062307-001GENTAMICIN SULFATEEQ 0.1% BASECREAM / TOPICALATRS, Approved before 19823f01610625f2…
2019-09-15 20:21 UTC2019-09A062307-001GENTAMICIN SULFATEEQ 0.1% BASECREAM / TOPICALATRS, Approved before 1982b00525d2431f…
2019-07-19 19:46 UTC2019-07A062307-001GENTAMICIN SULFATEEQ 0.1% BASECREAM / TOPICALATRS, Approved before 1982ea99ee380514…
2024-03-16 18:09 UTC · 4 captures of this ZIP2024-03A062307-001GENTAMICIN SULFATEEQ 0.1% BASECREAM / TOPICALATRS, Approved before 19826a51e52b5d6a…
2024-02-18 07:12 UTC2024-02A062307-001GENTAMICIN SULFATEEQ 0.1% BASECREAM / TOPICALATRS, Approved before 19821c564ffb4f44…
2023-12-20 04:57 UTC2023-12A062307-001GENTAMICIN SULFATEEQ 0.1% BASECREAM / TOPICALATRS, Approved before 1982ea1830bbd6c7…
2023-11-28 05:40 UTC · 2 captures of this ZIP2023-11A062307-001GENTAMICIN SULFATEEQ 0.1% BASECREAM / TOPICALATRS, Approved before 1982a72a2bbeb626…
2023-10-25 00:34 UTC · 2 captures of this ZIP2023-10A062307-001GENTAMICIN SULFATEEQ 0.1% BASECREAM / TOPICALATRS, Approved before 19829b2671bbb829…
2023-07-15 15:27 UTC · 2 captures of this ZIP2023-07A062307-001GENTAMICIN SULFATEEQ 0.1% BASECREAM / TOPICALATRS, Approved before 1982a67488948f0b…
2023-06-13 01:57 UTC · 3 captures of this ZIP2023-06A062307-001GENTAMICIN SULFATEEQ 0.1% BASECREAM / TOPICALATRS, Approved before 19823f0d92c62455…
2023-05-13 08:27 UTC2023-05A062307-001GENTAMICIN SULFATEEQ 0.1% BASECREAM / TOPICALATRS, Approved before 1982053a50430f4f…
2023-01-26 05:58 UTC2023-01A062307-001GENTAMICIN SULFATEEQ 0.1% BASECREAM / TOPICALATRS, Approved before 19823bdfa0b2c4d7…

Observed Orange Book normalized TE history#

Normalized TE history page 1 of 2 · 45 observed states.

Captured, Edition, Application-product table
CapturedEditionApplication-productTE codeOrderSource SHA-256
2026-11-14 07:37:172026-10A062307-001AT1d4dbc9d85df4…
2026-10-15 13:18:302026-09A062307-001AT1c2088c7a36db…
2026-09-14 22:38:342026-08A062307-001AT184e616aacf4f…
2026-08-18 06:07:402026-07A062307-001AT1caaa826d4ba7…
2026-02-19 14:30 UTC2026-02A062307-001AT1011fe1cb6892…
2025-12-14 10:44 UTC · 2 captures of this ZIP2025-12A062307-001AT131067a03dcf5…
2025-08-23 18:47 UTC2025-08A062307-001AT16a471c1ec25d…
2025-03-22 03:13 UTC · 3 captures of this ZIP2025-03A062307-001AT1fd3edfee7708…
2025-02-26 10:13 UTC · 3 captures of this ZIP2025-02A062307-001AT1b8a1b40f171c…
2025-01-19 17:59 UTC · 7 captures of this ZIP2025-01A062307-001AT103ed91905a0d…
2024-12-13 21:23 UTC · 2 captures of this ZIP2024-12A062307-001AT12680178bc6a6…
2024-09-14 05:58 UTC · 2 captures of this ZIP2024-09A062307-001AT15bbf6a4d5a75…
2024-11-08 22:44 UTC · 3 captures of this ZIP2024-11A062307-001AT1d8e5a09893c0…
2024-10-29 15:01 UTC2024-10A062307-001AT1d06236e962d9…
2024-08-13 05:28 UTC · 3 captures of this ZIP2024-08A062307-001AT179d66fd596c7…
2024-07-13 05:37 UTC · 2 captures of this ZIP2024-07A062307-001AT1301d65b070ca…
2024-06-18 03:08 UTC · 5 captures of this ZIP2024-06A062307-001AT11e350fbaab3a…
2024-05-31 18:47 UTC2024-05A062307-001AT18072bd15b7f6…
2022-06-29 02:47 UTC · 2 captures of this ZIP2022-06A062307-001AT15c6f7cd8ea54…
2022-04-08 23:34 UTC2022-04A062307-001AT15d02ea3f76ae…
2022-04-04 05:41 UTC2022-04A062307-001AT14b0b4de00fa7…
2019-12-13 00:20 UTC2019-12A062307-001AT174a2ff9319b5…
2022-03-09 01:35 UTC2022-03A062307-001AT1bb7c543d1eb4…
2021-12-28 21:50 UTC2021-12A062307-001AT1782e0a99824c…
2021-05-05 16:15 UTC · 3 captures of this ZIP2021-05A062307-001AT187673890dc5c…
2021-03-12 10:30 UTC2021-03A062307-001AT15aa47cf7b7d7…
2020-12-22 03:56 UTC2020-12A062307-001AT18869cabd3fbd…
2020-11-12 02:37 UTC2020-11A062307-001AT1c0c555d07b60…
2019-12-14 00:12 UTC2019-12A062307-001AT13f01610625f2…
2019-09-15 20:21 UTC2019-09A062307-001AT1b00525d2431f…
2019-07-19 19:46 UTC2019-07A062307-001AT1ea99ee380514…
2024-03-16 18:09 UTC · 4 captures of this ZIP2024-03A062307-001AT16a51e52b5d6a…
2024-02-18 07:12 UTC2024-02A062307-001AT11c564ffb4f44…
2023-12-20 04:57 UTC2023-12A062307-001AT1ea1830bbd6c7…
2023-11-28 05:40 UTC · 2 captures of this ZIP2023-11A062307-001AT1a72a2bbeb626…
2023-10-25 00:34 UTC · 2 captures of this ZIP2023-10A062307-001AT19b2671bbb829…
2023-07-15 15:27 UTC · 2 captures of this ZIP2023-07A062307-001AT1a67488948f0b…
2023-06-13 01:57 UTC · 3 captures of this ZIP2023-06A062307-001AT13f0d92c62455…
2023-05-13 08:27 UTC2023-05A062307-001AT1053a50430f4f…
2023-01-26 05:58 UTC2023-01A062307-001AT13bdfa0b2c4d7…

openFDA label cross-check#

OpenFDA label data provides additional search and identifier links. DailyMed’s Structured Product Label is the canonical label on FDA.report. Matching records are deduplicated before they are shown below.

Matched openFDA labels page 1 of 1 · 1 matching rows.

Brand, Generic, Manufacturer table
BrandGenericManufacturerSPL set IDEffective dateAvailable safety fieldsJoin
Gentamicin SulfateGENTAMICIN SULFATEPadagis Israel Pharmaceuticals Ltd4cfbe37e-11d6-46fc-b287-0561387b17b72023-01-31Adverse reactionsExact identifier
ndc (package): 45802-056-35
ndc (package): 45802-056-11
ndc (product): 45802-056
ndc11 (package): 45802005611
ndc11 (package): 45802005635
spl id: 11688357-e569-4785-a313-18115f24c5bb
spl set id: 4cfbe37e-11d6-46fc-b287-0561387b17b7

Reported adverse events (FAERS/openFDA)#

Adverse event summaries are temporarily unavailable. Other product information remains available.